摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[5-(chloromethyl)-2-pyridyl]-N,N-bis(2-pyridylmethyl)methanamine | 175858-94-3

中文名称
——
中文别名
——
英文名称
[5-(chloromethyl)-2-pyridyl]-N,N-bis(2-pyridylmethyl)methanamine
英文别名
1-(5-(chloromethyl)pyridin-2-yl)-N,N-bis(pyridin-2-ylmethyl)methanamine;5-chloromethyl-tris(2-pycolyl)amine;1-[5-(chloromethyl)pyridin-2-yl]-N,N-bis(pyridin-2-ylmethyl)methanamine
[5-(chloromethyl)-2-pyridyl]-N,N-bis(2-pyridylmethyl)methanamine化学式
CAS
175858-94-3
化学式
C19H19ClN4
mdl
——
分子量
338.84
InChiKey
AFKZBGOYHLJNSU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    466.1±40.0 °C(Predicted)
  • 密度:
    1.233±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    41.9
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [5-(chloromethyl)-2-pyridyl]-N,N-bis(2-pyridylmethyl)methanamine 在 tetrakis(actonitrile)copper(I) hexafluorophosphate 作用下, 以 乙腈 为溶剂, 反应 18.0h, 以84%的产率得到[5-(2-{6-[(Bis-pyridin-2-ylmethyl-amino)-methyl]-pyridin-3-yl}-ethyl)-pyridin-2-ylmethyl]-bis-pyridin-2-ylmethyl-amine
    参考文献:
    名称:
    双核铜配合物对 DNA 的高效和特异性链断裂:具有连接的三(2-吡啶基甲基)胺部分的配合物的比较反应性
    摘要:
    化合物 [Cu(II)(2)(D(1))(H(2)O)(2)](ClO(4))(4) (D(1) = 双核配体与两个 tris(2-吡啶基甲基)胺单元通过 -CH(2)CH(2)- 桥在其 5-吡啶基位置共价连接)选择性促进寡核苷酸链上 DNA 的切割,该链从磨损的双链结构的 3' 侧延伸至两个残基的位点从交界处移位。反应的最低要求包括与切割位点相邻的 3' 突出端的 n(即第一个未配对)位置的鸟嘌呤和 5' 突出端的 n 位置的腺嘌呤。识别和链断裂与切割位点的核碱基无关。还原剂和分子氧的必要存在表明负责裂解的中间体是通过双核络合物的铜 (I) 形式激活分子氧而产生的。对自由基猝灭剂缺乏敏感性和高水平的断裂位点选择性表明一种不涉及可扩散自由基物种的机制。与单核类似物 [Cu(II)(TMPA)(H(2)O)](ClO(4))(2)(TMPA = tris( 2-吡啶基甲基)胺)和 [Cu(OP)(2)](2+)(OP
    DOI:
    10.1021/ja020039z
  • 作为产物:
    描述:
    2,5-吡啶-二羧酸二甲酯 在 selenium(IV) oxide 、 sodium tetrahydroborate 、 氯化亚砜碳酸氢钠 作用下, 以 1,4-二氧六环甲醇氯仿乙腈 为溶剂, 反应 58.0h, 生成 [5-(chloromethyl)-2-pyridyl]-N,N-bis(2-pyridylmethyl)methanamine
    参考文献:
    名称:
    基因靶向的聚吡啶基三链体形成寡核苷酸杂交体的开发。
    摘要:
    据报道,点击化学方法可靶向DNA氧化,其中叠氮化物修饰的三脚架配体与炔烃-TFO偶联。在协调的Cu II存在下,这些杂种可以有效地靶向和切割富含嘌呤的遗传元件。
    DOI:
    10.1002/cbic.202000408
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS<br/>[FR] COMPOSÉS
    申请人:UNIV OSLO
    公开号:WO2018033719A1
    公开(公告)日:2018-02-22
    The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a β-lactam antibiotic, wherein said compound has the general formula I: (I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g. 5 or 6-membered heterocyclic rings (such rings preferably include at least one heteroatom selected from N, S and O, preferably N); wherein any optional substituents may be selected from C1-6 alkyl, C1-6 alkoxy, halogen, nitro, cyano, amine, and substituted amine; each L, which may be the same or different, is a covalent bond or a linker; each W, which may be the same or different, is a non-peptidic hydrophilic group which comprises one or more hydroxy groups; and x is an integer from 1 to 3) or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof.
    该发明提供了一种化合物,用于治疗和/或预防人类或非人哺乳动物体内的细菌感染,所述方法包括将该化合物与β-内酰胺类抗生素(可以同时、分开或顺序地)结合给药,其中所述化合物具有一般式I:(I)(其中:Q是一个亲脂性、选择性结合Zn2+离子的基团,包括至少一个,最好是两个或更多(例如2、3或4个),可选择地取代的不饱和杂环环,例如5或6元杂环环(这些环最好包括至少一个从N、S和O中选择的杂原子,最好是N);其中任何可选择的取代基可以选择自C1-6烷基、C1-6烷氧基、卤素、硝基、基、胺和取代胺;每个L,可以相同也可以不同,是一个共价键或一个连接基;每个W,可以相同也可以不同,是一个非肽性亲基团,包括一个或多个羟基;x是1到3之间的整数)或其立体异构体、药学上可接受的盐或前药。
  • Synthesis and Characterization of PY2- and TPA-Appended Diphenylglycoluril Receptors and Their Bis-CuI Complexes
    作者:Vera S. I. Sprakel、Johannes A. A. W. Elemans、Martin C. Feiters、Baldo Lucchese、Kenneth D. Karlin、Roeland J. M. Nolte
    DOI:10.1002/ejoc.200500865
    日期:2006.5
    A number of metallohosts mimicking dinuclear copper oxygenases have been designed and synthesized. These metallohosts combine a substrate binding site, i.e. the diphenylglycoluril basket receptor, with two types of metal-binding ligands, viz. tri-coordinating bis(2-ethylpyridine)amine (PY2) and tetra-coordinating tris(2-methylpyridine)amine (TPA). The preparation of the bis-Cu I complexes of the ligand
    已经设计并合成了许多模拟双核加氧酶的属宿主。这些属宿主将底物结合位点(即二苯基甘篮式受体)与两种类型的属结合配体(即。三配位双(2-乙基吡啶)胺(PY2)和四配位三(2-甲基吡啶)胺(TPA)。配体双Cu I配合物的制备
  • Compounds
    申请人:UNIVERSITETET I OSLO
    公开号:US10961223B2
    公开(公告)日:2021-03-30
    The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a β-lactam antibiotic, wherein said compound has the general formula I: (I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g. 5 or 6-membered heterocyclic rings (such rings preferably include at least one heteroatom selected from N, S and O, preferably N); wherein any optional substituents may be selected from C1-6 alkyl, C1-6 alkoxy, halogen, nitro, cyano, amine, and substituted amine; each L, which may be the same or different, is a covalent bond or a linker; each W, which may be the same or different, is a non-peptidic hydrophilic group which comprises one or more hydroxy groups; and x is an integer from 1 to 3) or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof.
    本发明提供了用于治疗和/或预防人类或非人类哺乳动物细菌感染的方法的化合物,所述方法包括将所述化合物与β-内酰胺类抗生素(同时、分别或依次)联合给药,其中所述化合物具有通式I: (I) (其中:Q 是对 Zn2+ 离子有选择性的亲脂性螯合基团,它包括至少一个,最好是两个或更多 (例如 2、3 或 4 个)任选取代的不饱和杂环,例如5或6元杂环(此类环最好包括至少一个选自N、S和O的杂原子,最好是N);其中任选取代基可选自C1-6烷基、C1-6烷氧基、卤素、硝基、基、胺和取代胺;每个 L(可以相同或不同)是共价键或连接体;每个 W(可以相同或不同)是非肽亲基团,包括一个或多个羟基;以及 x 是 1 至 3 的整数)或其立体异构体、药学上可接受的盐或原药。
  • Reversible O2 Binding to a Dinuclear Copper(I) Complex with Linked Tris(2-pyridylmethyl)amine Units: Kinetic-Thermodynamic Comparisons with Mononuclear Analogs
    作者:Dong-Heon Lee、Ning Wei、Narasimha N. Murthy、Zoltan Tyeklar、Kenneth D. Karlin、Susan Kaderli、Bernhard Jung、Andreas D. Zuberbuehler
    DOI:10.1021/ja00155a014
    日期:1995.12
    fajThe kinetics and thermodynamics of reaction of O-2 with copper(I) complexes can provide fundamental information relevant to chemical and biological systems. Using diode-array variable-temperature (180-296 K) stopped-flow kinetic methods, we report detailed information on the O-2 reactivity (in EtCN) of dicopper(I) complex [(D-1)Cu-2(I)(RCN)(2)](2+) (2a) (R = Me or Et) [D-1 = dinucleating ligand with a -CH2CH2- group linking two tris(2-pyridylmethyl)amine (TMPA) units at a 5-pyridyl position of each tetradentate moiety]. A comparative study of mononuclear complex [(TMPAE)Cu(RCN)li (1a') [TMPAE has a -C(O)OCH3 ester substituent in the 5-position of one pyridyl group of TMPA] has been carried out. The results are compared with data from the previously investigated complex [(TMPA)Cu(RCN)](+) (1a). The syntheses of D-1 and 2a-(ClO4)(2) are described; an X-ray structure reveals two pentacoordinate Cu(I) ions (Cu ... Cu = 11.70 Angstrom), each bound by the N-4-tetradentate and an EtCN molecule. Cyclic voltammetric data for 1a' and 2a are reported. At 193 K in EtCN, 2a reacts with O-2 (Cu/O-2 = 2:1, manometry) to produce an intensely purple colored solution of adduct [(D-1)Cu-2(O-2)](2+) (2c), lambda(max) = 540 nm (epsilon 11 100 M(-1) cm(-1)). This peroxo-dicopper(II) species reacts with PPh(3), liberating O-2 and producing the isolatable bis-phosphine adduct [(D')Cu-2(PPh(3))(2)](2+). The kinetic investigation provides spectral characterization of transient Cu/O-2 1:1 adducts generated upon oxygenation of cold solutions of 1a' or 2a. [(TMPAE)Cu(O-2)](+) (1b') forms reversibly (lambda(max) = 415 nm) with k(1) (8.2 +/- 0.4) x 10(3) M(-1) s(-1) and K-1 = k(1)/k(-1) = (284 +/- 9) M(-1) at 183 K, with Delta H-1 degrees (-32 +/- 1) kJ mol(-1), Delta S-1 degrees = (-127 +/- 3) J K-1 mol(-1). Two types of Cu(II)-O-2(-) complexes form in the reaction of 2a: a 2:1 open form (i.e., [(D-1)Cu-2(O-2)(EtCN)](2+), 2b) and a bis-O-2 2:2 open adduct (i.e., [(D-1)Cu-2(O-2)(2)](2+), 2b'). For the formation of 2b, k(1) (1.63 +/- 0.01) x 10(4) M(-1) s(-1) and K-1 = (2.03 +/- 0.04) x 10(3) M(-1) at 183 K. Complexes 2b and 2b' have identical spectroscopic properties (lambda(max) = 416 nm, epsilon = 4500 M(-1) cm(-1)) per Cu-O-2 unit, and their rate constants are statistically related. Intermediates 1b' and 2b further convert into (mu-peroxo)dicopper(II) [(2 Cu):(1 O-2)] complexes. [((TMPAE)Cu)(2)(O-2)](2+) (1c') (lambda(max) = 532 nm, epsilon = 9380 M(-1) cm(-1)) forms in a second-order reaction of 1b' with 1a' with K1K2 = (2.1 +/- 0.4) X 10(11) M(-2) at 183 K (Delta H(12)degrees = -77 +/- 1 kJ mol(-1) and Delta S(12)degrees = -203 +/- 5 J K-1 mol(-1)), while [D-1)Cu-2(O-2)](2+) (2c) (lambda(max) 540 nn, epsilon = 11 100 M(-1) cm(-1)) is generated from 2b in an intramolecular reaction, with k(2) = (3.51 +/- 0.05) x 10(1) s(-1) and k(on), = k(1)k(2)/k(-1) (7.1 +/- 0.2) x 10(4) M-l s(-1) (183 K). The overall formation of 2c is faster than for 1c' or [((TMPA)Cu)(2)(O-2)](2+) (1c) because of a more positive entropy of activation (Delta S-on(double dagger), = (-139 +/- 3) J K-1 mol(-1) for 2c vs Delta S-on(double dagger) = (-201 +/- 5) J K-1 mol(-1) for 1c). However, this significantly enhanced kinetic reactivity (for 2a --> 2c) is not reflected by an analogous increase in thermodynamic stability. [(D-1)Cu-2(O-2)](2+) (2c) is enthalpically less stable (Delta H(12)degrees = (-34.8 +/- 0.4) kJ mol(-1)) than Cu2O2 species 1c and 1c' (Delta H(12)degrees = -81 to -77 kJ mol(-1), respectively), which are formed from mononuclearprecursors. There is a substantially larger overall formation entropy for 2c [Delta S(12)degrees = (-89.3 +/- 1.5) J K-1 mol(-1) compared to -220 and -203 J K-1 mol(-1) for 1c and 1c', respectively] since Cu2O2 formation is an intramolecular, rather than intermolecular, process. Examination of other kinetic parameters and spectral differences provides complementary information that 2c has a strained structure. In fact, 2c is not the ultimate oxidation product: relief of steric constraints occurs at higher temperatures by a slow rearrangement (lambda(max) = 540 nm --> lambda(max) = 529 nm) producing (Cu2O2)(n) oligomers containing intermolecular Cu-O-2-Cu bonds. A particularly stable trimer species [((D-1)Cu-2(O-2))(3)](6+) (2d) was characterized, with Delta H-3 degrees (-153 kJ mol(-1))/3 = -51 KJ mol(-1) per Cu2O2 unit, intermediate between that seen for 2c, 1c, and 1c'. Thus, (peroxo)dicopper(II) complexes formed from mononuclear precursors are the most stable, while secondary rearrangements within intramolecularly formed Cu-2-O-2 complexes with dinucleating ligands can and do occur. Comparisons are made with relevant copper-dioxygen complexes, and the chemical and biological relevance of this chemistry is discussed.
  • ZINC CHELATING COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTION
    申请人:Universitetet I Oslo
    公开号:EP3497095B1
    公开(公告)日:2021-07-14
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-